俊宏固肾生发丸品牌怎么样 申请店铺

我要投票 俊宏固肾生发丸在生发行业中的票数:647 更新时间:2025-09-14
俊宏固肾生发丸是哪个国家的品牌?「俊宏固肾生发丸」是 吉林省俊宏药业有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人张士俊在2001-09-04期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力俊宏固肾生发丸品牌出海!将品牌入驻外推网,定制俊宏固肾生发丸品牌推广信息,可以显著提高俊宏固肾生发丸产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

俊宏固肾生发丸怎么样

辉南县位于中药材资源丰富的长白山麓松花江畔,地处吉林省东南部,隶属通化市管辖,东南与靖宇县毗邻,西距梅河口市45公里,南与柳河县接壤,东与桦甸市相边,北与磐石市隔江相望,县城朝阳镇位于辉南县西北角部,素有“参鹿之乡,医药名城”之美誉。俊宏药业有限公司就位于县城东北部,辉南经济开发区内。

俊宏药业有限公司成立于1990年,注册资金5000万元,2001年由长春搬迁到辉南,并按GMP标准实施改造工程。于2003年初整体通过了国家药品GMP认证并投入正式生产。公司类型为民营有限责任公司,资产总额5.5亿元。公司占地面积21万平方米,建筑面积5.8万平方米,现有员210人,各类专业技术人员70余人,其中具有高级职称9人,职业药师7人。公司现有前处理提取车间、固体制剂车间、保健用品车间、中心化验室等四个车间和七个职能管理科室。有胶囊剂、片剂、颗粒剂、散剂、水丸、蜜丸、浓缩丸、水蜜丸、糊丸、中药饮片和贴膏剂、软膏剂、液体制剂等13个剂型,共有87个国药准字号中成药生产品种和33个吉卫健用字号保健用品生产品种,其中获国家中药保护品种1个。公司拥有完备的生产设备和精湛的工艺技术,是一个已通过新修订的国家药品GMP认证、以固体制剂为主体的现代化中成药制药和保健用品生产企业。

公司自成立以来一贯奉行以市场为导向,以产品为载体,以质量为生命的生产经营宗旨。按照现代化企业制度的要求,规范管理机制,强化营销策略,坚持内抓管理,外拓市场,以质量求生存,靠信誉求发展的经营理念。凭借高质量的产品和良好的商业信誉,已在全国大部分省市建立了自己的销售网络,产品销售量逐年增加,各项经济指标逐年增长。

公司把建设“规模强大,实力雄厚,效益显著”的科技创新型企业作为发展战略,已与省中医药研究院、吉大药学院等科研机构、大专院校建立了合作关系,成功开发了一系列新药特药,其中研制开发的保健用品产品种已获批号33个,目前已正式投产上市,公司将不断研制开发高科技新产品,以使企业实力不断增强,朝更高、更强的目标迈进,为医药行业的繁荣发展而做出贡献。


Huinan County is located on the Bank of Songhua River at the foot of Changbai Mountain, which is rich in traditional Chinese medicine resources. It is under the jurisdiction of Tonghua city. It is adjacent to Jingyu County in the southeast, 45km away from Meihekou city in the west, Liuhe County in the south, Huadian City in the East and Panshi City in the north. Chaoyang Town, located in the northwest corner of Huinan County, is known as the "hometown of shenlu and famous medical city". Junhong Pharmaceutical Co., Ltd. is located in Huinan Economic Development Zone in the north of the east of the county. Junhong Pharmaceutical Co., Ltd. was founded in 1990 with a registered capital of 50 million yuan. It was moved from Changchun to Huinan in 2001, and the transformation project was implemented according to GMP standards. At the beginning of 2003, it passed the national GMP certification and put into formal production. The company is a private limited liability company with total assets of RMB 550 million. The company covers an area of 210000 square meters, with a building area of 58000 square meters. There are 210 employees and more than 70 professional and technical personnel, including 9 with senior titles and 7 professional pharmacists. The company has four workshops and seven functional management departments, including pretreatment and extraction workshop, solid preparation workshop, health care supplies workshop, and central laboratory. There are 13 dosage forms including capsule, tablet, granule, powder, water pill, honey pill, concentrated pill, water honey pill, paste pill, Chinese herbal pieces and pastes, ointment, liquid preparation, etc. there are 87 production varieties of Chinese patent medicine under the state drug registration number and 33 production varieties of health care products under the Ji Wei Jian use number, of which one is under the state protection of traditional Chinese medicine. The company has complete production equipment and exquisite technology. It is a modern Chinese patent medicine and health care products manufacturer that has passed the newly revised national GMP certification and takes solid preparations as the main body. Since its establishment, the company has always adhered to the production and operation tenet of market-oriented, product-oriented and quality-oriented. According to the requirements of modern enterprise system, standardize the management mechanism, strengthen the marketing strategy, adhere to the business philosophy of internal management, external market expansion, survival by quality and development by reputation. With high-quality products and good business reputation, we have established our own sales network in most provinces and cities of the country. The sales volume of products increases year by year, and the economic indicators increase year by year. The company takes the construction of a scientific and technological innovation enterprise with "strong scale, strong strength and remarkable benefits" as its development strategy. It has established cooperative relations with scientific research institutions and colleges and universities such as Provincial Institute of traditional Chinese medicine, Jida College of medicine, etc., and has successfully developed a series of new drugs and specialty drugs, including 33 batches of health care products, which have been officially put into production and listed. The company will We will continue to develop new high-tech products, so as to enhance the strength of the enterprise, move towards a higher and stronger goal, and contribute to the prosperity and development of the pharmaceutical industry.

本文链接: https://brand.waitui.com/e70e8902c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

国际能源署:低排放氢气项目面临阻力但仍将强劲增长

国际能源署9月12日发布《2025年全球氢能评估》报告说,尽管面临多重阻力,但预计到2030年,低排放氢气项目仍将强劲增长。报告显示,2024年全球氢气需求增至近1亿吨,较2023年增长2%,与整体能源需求增长保持一致,其中绝大部分由未采取减排措施的化石燃料制氢满足。炼油和工业等传统使用氢气的行业仍是最大用户。 (新华社)

32分钟前

因安全带问题,沃尔沃在美召回1355辆汽车

9月13日,据美国国家公路交通安全管理局(NHTSA)披露,沃尔沃汽车将召回部分2026款XC90 MHEV、XC60 MHEV、V90CC MHEV和V60CC MHEV车型,共计1355辆。召回原因为前排安全带卷收器中的扭力杆可能在生产过程中受损。经销商将免费更换两个前排安全带卷收器。(界面)

32分钟前

波音因安全违规面临美监管机构310万美元罚款

美国联邦航空管理局12日发布声明说,由于波音公司在2023年9月至2024年2月期间有安全违规行为,拟对其处以总额约310万美元的罚款。声明说,波音安全违规行为涉及2024年1月5日发生的舱门塞(内嵌式应急门)脱落事故以及干涉飞机安全相关人员独立履职等问题,美国联邦航空管理局依法采取法定最高额民事处罚。(新华社)

32分钟前

宗馥莉或另立门户 启用新品牌“娃小宗”

据蓝鲸新闻,从多个信源了解到,娃哈哈或使用新品牌“娃小宗”。据杭州娃哈哈宏辉食品饮科有限公司的一份内部文件显示,自娃哈哈集团创始人离世后,公司一直努力推进解决各项历史相关遗留问题,为维护“娃哈哈”品牌使用的合规性,公司决定从2026年新的销售年度起,更换使用新品牌“娃小宗”。 (财联社)

32分钟前

贝莱德将在特朗普访英期间公布价值5亿英镑的数据中心投资计划

全球规模最大的资产管理公司将借特朗普总统下周对英国进行国事访问之机,公布一项价值5亿英镑的英国数据中心投资计划。据了解,贝莱德集团计划宣布与数字基础设施投资管理公司Digital Gravity Partners成立合资企业。该合资企业将专注于收购现有数据中心,并对其进行现代化改造,以提升承载能力。(新浪财经)

32分钟前

本页详细列出关于俊宏固肾生发丸的品牌信息,含品牌所属公司介绍,俊宏固肾生发丸所处行业的品牌地位及优势。
咨询